Pharmacolinx Inc. is currently researching and developing host-directed antiviral drugs that can be used on humans, animals, fish, and shellfish and plans to commercialize them after safety and clinical trials.

In the future, Pharmacolinx Inc. will differentiate and develop into a company specializing in R&DB for the prevention, diagnosis, and treatment of various diseases occurring in human, veterinary, and farmed fish and shellfish.